NEW YORK (GenomeWeb News) – As translational medicine and genetic- and genomic-based diagnostic tests proliferate, some core laboratories that usually support basic research are looking to move into clinical testing. While such a move may make sense for some labs, there are a number of issues that should be considered and addressed, and understanding how such clinical labs are regulated is chief among them.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: caution urged in use of gene drives, and more.

NIH's Sally Rockey examines the tapped and untapped potential of the NIH peer reviewer pool.

PLOS Biology has asked researchers how they envision the future of genetics and genomics.

Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."